IBIO
iBio, Inc. Common Stock
NASDAQ: IBIO · HEALTHCARE · BIOTECHNOLOGY
$1.59
-5.92% today
Updated 2026-05-01
Market cap
$57.47M
P/E ratio
—
P/S ratio
191.56x
EPS (TTM)
$-1.00
Dividend yield
—
52W range
$1 – $4
Volume
1.0M
iBio, Inc. Common Stock (IBIO) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+17.4%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+81.3%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-7.8%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-8.3%
2026-02-10
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-10 | $-0.09 | +79.1% | $2.41 | $2.21 | -8.3% |
| 2025-11-12 | $-0.29 | +32.6% | $1.24 | $1.15 | -7.3% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.43 | $-0.09 | +79.1% | — | — |
| 2025-09-30 | $-0.43 | $-0.29 | +32.6% | $100000.00 | — |
| 2025-06-30 | $-0.36 | $-0.32 | +11.1% | $200000.00 | +14.3% |
| 2025-03-31 | $-0.32 | $-0.49 | -53.1% | — | — |
| 2024-12-31 | $-0.46 | $-0.48 | -4.3% | $200000.00 | — |
| 2024-09-30 | $-0.46 | $-0.46 | +0.0% | — | — |
| 2024-06-30 | $-0.47 | $-0.90 | -91.9% | $175000.00 | — |
| 2024-03-31 | — | $-0.85 | — | — | — |
| 2023-12-31 | — | $-4.42 | — | — | — |
| 2023-09-30 | — | $-0.24 | — | $50000.00 | — |
| 2023-06-30 | $-0.41 | $0.26 | +163.4% | — | — |
Frequently asked questions
Has iBio, Inc. Common Stock beaten earnings estimates?
iBio, Inc. Common Stock has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +17.4% over the last 4 quarters.
How does IBIO stock react to earnings?
IBIO stock has moved an average of -7.8% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.